Parallel Advisors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,640
Closed -$23.3K 3552
2025
Q1
$23.3K Buy
+3,640
New +$35.1K ﹤0.01% 2059
2024
Q4
Sell
-22
Closed -$609 3524
2024
Q3
$609 Buy
+22
New +$550 ﹤0.01% 3148
2023
Q2
Sell
-78
Closed -$581 3363
2023
Q1
$581 Sell
78
-219
-74% -$2.18K ﹤0.01% 3074
2022
Q4
$3.5K Buy
297
+219
+281% +$2.5K ﹤0.01% 2472
2022
Q3
$1K Hold
78
﹤0.01% 2848
2022
Q2
$1K Buy
+78
New +$1.57K ﹤0.01% 2698

Other funds holding ASPN

Parallel Advisors's ASPN Position: Q2 2025 in Review

Parallel Advisors sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 3,640 shares — an estimated $23.3K sold.

Parallel Advisors first reported a position in ASPN in Q2 2022 and held it in 6 quarters. The position peaked at $23.3K in Q1 2025. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

  • Parallel Advisors reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
  • Parallel Advisors sold 3,640 Aspen Aerogels shares in Q2 2025, an estimated $23.3K.
  • Parallel Advisors first reported a position in Aspen Aerogels in Q2 2022 and held it in 6 quarters.
  • Parallel Advisors's Aspen Aerogels position peaked at $23.3K in Q1 2025.
  • 182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.